Elazer Edelman - Echo Therapeutics Director
Director
Dr. Elazer Edelman M.D. Ph.D. is Director of the Company. Dr. Edelman directs the HarvardMIT Biomedical Engineering Center dedicated to applying the rigors of the physical sciences to elucidate fundamental biologic processes and mechanisms of disease. Dr. Edelman received BS degrees in Bioelectrical Engineering and in Applied Biology a Masters of Science degree in Electrical Engineering and Computer Sciences from MIT and a Ph.D. in Medical Engineering and Medical Physics from MIT and an M.D. degree from Harvard Medical School. Dr. Edelman is a fellow of the National Academy of Engineering National Academy of Medicine and the American Academy of Arts and Science. He recently received the 2015 Lifetime Achievement Award from the International Conference of Innovation . He has trained more than 300 students and fellows and authored or coauthored more than 275 original scientific publications. Dr. Edelman was assigned several administrative and committee positions including a seat on the Science Board of the Food and Drug Administration . since 2015.
| Tenure | 9 years |
| Phone | 732-201-4189 |
| Web | http://www.echotx.com |
Echo Therapeutics Management Efficiency
The company has return on total asset (ROA) of (359.77) % which means that it has lost $359.77 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.649) %, meaning that it created substantial loss on money invested by shareholders. Echo Therapeutics' management efficiency ratios could be used to measure how well Echo Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 3.52 M in liabilities with Debt to Equity (D/E) ratio of 0.03, which may suggest the company is not taking enough advantage from borrowing. Echo Therapeutics has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Echo Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Echo Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Echo Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Echo to invest in growth at high rates of return. When we think about Echo Therapeutics' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| David Checketts | JetBlue Airways Corp | 60 | |
| Anthony ONeill | American Airlines Group | 58 | |
| Rafael Arias | Copa Holdings SA | N/A | |
| Peter Boneparth | JetBlue Airways Corp | 57 | |
| Anastasios David | Aegean Airlines SA | 43 | |
| Jose Velez | Copa Holdings SA | 75 | |
| Steve Albrecht | SkyWest | 71 | |
| Virginia Gambale | JetBlue Airways Corp | 58 | |
| Michael Embler | American Airlines Group | 53 | |
| Byron Grote | American Airlines Group | 67 | |
| John Cahill | American Airlines Group | 60 | |
| Meredith Siegfried | SkyWest | 40 | |
| Thomas Winkelmann | JetBlue Airways Corp | 57 | |
| Anastassis David | Aegean Airlines SA | 46 | |
| Anne Stevens | American Airlines Group | 67 | |
| Richard Kraemer | American Airlines Group | 73 | |
| Ronald Mittelstaedt | SkyWest | 54 | |
| John Gebo | Copa Holdings SA | 50 | |
| Alberto Ibarguen | American Airlines Group | 72 | |
| Vittorio Pisante | Aegean Airlines SA | 47 | |
| Jens Bischof | JetBlue Airways Corp | 48 | |
Management Performance
| Return On Equity | -3.65 | |||
| Return On Asset | -359.77 |
Echo Therapeutics Leadership Team
Elected by the shareholders, the Echo Therapeutics' board of directors comprises two types of representatives: Echo Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Echo. The board's role is to monitor Echo Therapeutics' management team and ensure that shareholders' interests are well served. Echo Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Echo Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Goldberg, Director | ||
| Scott Hollander, CEO and President and Director | ||
| Elazer Edelman, Director | ||
| Christine Olimpio, Director of Investor Relations and Corporate Communications | ||
| Alan Schoenbart, CFO | ||
| Shepard Goldberg, Director |
Echo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Echo Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.65 | |||
| Return On Asset | -359.77 | |||
| Current Valuation | 3.43 M | |||
| Shares Outstanding | 12 M | |||
| Number Of Shares Shorted | 273.27 K | |||
| Price To Earning | (0.03) X | |||
| Price To Book | 3.11 X | |||
| Price To Sales | 990.09 X | |||
| Revenue | 5.12 K | |||
| Gross Profit | 5.12 K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Echo Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Echo Therapeutics' short interest history, or implied volatility extrapolated from Echo Therapeutics options trading.
Pair Trading with Echo Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Echo Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Echo Therapeutics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to GE Aerospace could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GE Aerospace when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GE Aerospace - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GE Aerospace to buy it.
The correlation of GE Aerospace is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as GE Aerospace moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if GE Aerospace moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for GE Aerospace can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Echo Stock
If you are still planning to invest in Echo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Echo Therapeutics' history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |